Image cytometric measurement of nuclear proliferation markers (MIB-1, PCNA) in astrocytomas: Prognostic significance

American Journal of Clinical Pathology

Volumn 109, Issue 1, 1998, Pages 69-74

  Kirkegaard, Lewis J ^a   DeRose, Patricia B ^a   Yao, Bin ^a   Cohen, Cynthia ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Astrocytoma; Image cytometry; MIB 1; Proliferating cell nuclear antigen PCNA ; Proliferation

Indexed keywords

CYCLINE; KI 67 ANTIGEN; MONOCLONAL ANTIBODY KI 67;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CANCER SURVIVAL; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMAGE CYTOMETRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY;

EID: 0031973661     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.1.69     Document Type: Article

References (36)

1. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas: a simple and reproducible method. Cancer. 1988;62:2152-2165.
2. Kim TS, Halliday AL, Hedley-Whyte ET, Convery K. Correlates of survival and the Daumas-Duport grading system for astrocytomas. J Neurosurg. 1991;74:27-37.
3. Wang H-C, Ho Y-S. Clinicopathological evaluation of 78 astrocytomas in Taiwan with emphasis on a simple grading system. J Neurooncol. 1992;13:265-276.
4. Danova M, Riccardi A, Mazzini G, et al. Ploidy and proliferative activity of human brain tumors: a flow cytofluorometric study. Oncology. 1987;44:102-107.
5. Wolley RC, Kawamoto K, Herz F, Hirano A, Koss LG. Flow cytometry of human brain rumors. In: Zimmerman HM, ed. Progress in Neuropathology. New York, NY: Raven;1979;4:267-276.
6. Plate KH, Arndt D, Hellwig D, Ruschoff J, Mennel HD. Assessment of histogenesis and proliferative potential in cytologic specimens of human brain tumors: value of immunocytochemistry and nucleolar organizer regions. Anal Quant Cytol Histol. 1990;12:157-164.
7. Shibuya M, Ito S, Miwa T, et al. Proliferative potential of brain tumors: analyses with Ki-67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxyuridine labeling, and nucleolar organizer region counts. Cancer. 1993; 71:199-206.
8. Korkolopoulou P, Christodoulou P, Papanikolaou A, Thomas-Tsagli E. Proliferating cell nuclear antigen and nucleolar organizer regions in CNS tumors: correlation with histological type and tumor grade. Am J Surg Pathol. 1993;17:912-919.
9. Onda K, Davis RL, Shibuya M, Wilson CB, Hoshino T. Correlation between the bromodeoxyuridine labeling index and the MIB-1 and Ki-67 proliferating cell indices in cerebral gliomas. Cancer. 1994;74:1921-1926.
10. Theunissen PHMH, Blaauw G. Proliferating cell nuclear antigen immunostaining and survival in cerebral astrocytoma. Histopathology. 1993;23:75-79.
11. Louis DN, Edgerton S, Thor AD, Hedley-Whyte ET. Proliferating cell nuclear antigen and Ki-67 immunohistochemistry in brain tumors: a comparative study. Acta Neuropathol (Berl). 1991;81:675-679.
12. Haapasalo HK, Sallinen PK, Helen PT, et al. Comparison of three quantitation methods for PCNA immunostaining: applicability and relation to survival in 83 astrocytic neoplasms. J Pathol. 1993;171:207-214.
13. Burger PC, Shibata T, Kleihues P. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology. Am J Surg Pathol. 1986;10:611-617.
14. Jaros E, Perry RH, Adam L, et al. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours. Br J Cancer. 1992;66:373-385.
15. Schroder R, Bien K, Kott R, Meyers I, Vossing R. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time. Acta Neuropathol (Berl). 1991; 82:389-394.
16. Tan C-K, Castillo C, So AG, Downy KM. An auxiliary protein for DNA polymerase-delta from fetal calf thymus. J Biol Chem. 1986;261:12310-12316.
17. Prelich G, Tan CK, Kostura M, et al. Functional identity of proliferating cell nuclear antigen and DNA polymerase-delta of auxiliary protein. Nature. 1987;326:517-520.
18. Bravo R, Frank R, Blundell PA, Mac Donald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature. 1987;326:515-520.
19. Celis JE, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A. 1985;82:3262-3266.
20. Mathews MB, Bernstein RM, Franza BR, Garrels JI. Identity of the proliferating cell nuclear antigen and cyclin. Nature. 1984;309:374-376.
21. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984; 133:1710-1715.
22. Gerdes J, Li L, Schlueter C, et al. Immunobiochemical and molecular biologic characterization of the cell proliferation-associated nuclear antigen that is defined by monoclonal antibody Ki-67. Am J Pathol 1991;138:867-873.
23. McCormick D, Chong H, Hobbs C, Datta C, Hall PA. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1. Histopathology. 1993;22:355-360.
24. Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol. 1992;168:357-363.
25. Sallinen PK, Haapasalo HK, Visakorpi T, et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples. J Pathol. 1994;174:275-282.
26. Montine TJ, Vandersteenhoven JJ, Aguzzi A, et al. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms. Neurosurgery. 1994;34:674-678.
27. Parisi JE, Scheithauer BW. Glial tumors. In: Nelson JS, Parisi JE, Schochet SS, eds. Principles and Practice of Neuropathology. St Louis, Mo: Mosby-Year Book; 1993:123-183.
28. Brigati DJ, Budgeon LR, Unger ER, et al. Immunocytochemistry is automated: development of a robotic workstation based upon the capillary action principle. J Histotechnol. 1988;11:165-183.
29. Kennedy JC, El-Badawy N, DeRose PB, Cohen C. Comparison of cell proliferation in breast carcinoma using image analysis (Ki-67) and flow cytometric systems. Anal Quan Cytol Histol. 1992;14:304-311.
30. Baddoura FK, Cohen C, Unger ER, DeRose PB, Chenggis M. Image analysis for quantitation of estrogen receptor in formalin-fixed paraffin-embedded sections of breast carcinoma. Mod Pathol. 1991;4:91-95.
31. Hall PA, Levison DA, Woods AL, et al. Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol. 1990;162:285-294.
32. Schwarting R. Little missed markers and Ki-67. Lab Invest. 1993;68:597-599.
33. Leong AS-Y, Milios J, Tang SK. Is immunolocalisation of proliferating cell nuclear antigen (PCNA) in paraffin sections a valid index of cell proliferation? Appl Immunohistochem. 1993;1:127-135.
34. Wakimoto H, Aoyagi M, Nakayama T, et al. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas. Cancer. 1996;77:373-380.
35. Pollack IF, Campbell JW, Hamilton RL, Martinez AJ, Bozik ME. Proliferation index as a predictor of prognosis in malignant gliomas of childhood. Cancer. 1997;79:849-856.
36. Kiss R, DeWitte O, Decaestecker C, et al. The combined determination of proliferative activity and cell density in the prognosis of adult patients with supratentorial high-grade astrocytic tumors. Am J Clin Pathol. 1997;107:321-331.